Jamieson Wellness Inc. (TSX:JWEL)
Canada · Delayed Price · Currency is CAD 45.67
-0.07 (-0.15%)
Aug 20, 2026, 4:00 PM EST
Jamieson Wellness Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 880.58 | 822.06 | 733.78 | 676.17 | 547.37 | 451.03 | |
Revenue Growth | 14.96% | 12.03% | 8.52% | 23.53% | 21.36% | 11.73% |
Cost of Revenue | 511.8 | 483.72 | 458.01 | 434.17 | 348.24 | 288.59 |
Gross Profit | 368.78 | 338.33 | 275.78 | 242 | 199.13 | 162.44 |
Selling, General & Admin | 229.34 | 216.16 | 174.49 | 131.92 | 97.32 | 78.33 |
Operating Expenses | 238.17 | 224.57 | 181.76 | 137.79 | 102.23 | 82.5 |
Operating Income | 130.6 | 113.76 | 94.02 | 104.21 | 96.9 | 79.94 |
Interest Expense | -23.18 | -25.84 | -29 | -27.62 | -12.42 | -5.66 |
Currency Exchange Gain (Loss) | 1.53 | -1.85 | -1.48 | -1.96 | -0.27 | 0.09 |
Other Non Operating Income (Expenses) | -2.17 | - | - | - | - | - |
EBT Excluding Unusual Items | 106.78 | 86.07 | 63.54 | 74.63 | 84.22 | 74.37 |
Merger & Restructuring Charges | 3.77 | 3.77 | 12.43 | -8.96 | -13.71 | - |
Other Unusual Items | - | - | -0.17 | - | - | -3.91 |
Pretax Income | 110.54 | 89.84 | 75.8 | 65.67 | 70.5 | 70.47 |
Income Tax Expense | 29.18 | 25.37 | 24.67 | 19.63 | 17.7 | 18.38 |
Earnings From Continuing Operations | 81.36 | 64.46 | 51.13 | 46.04 | 52.81 | 52.08 |
Minority Interest in Earnings | -2.79 | -2.03 | 0.78 | 1.84 | - | - |
Net Income | 78.57 | 62.44 | 51.91 | 47.88 | 52.81 | 52.08 |
Net Income to Common | 78.57 | 62.44 | 51.91 | 47.88 | 52.81 | 52.08 |
Net Income Growth | 35.47% | 20.27% | 8.42% | -9.33% | 1.39% | 25.20% |
Shares Outstanding (Basic) | 42 | 42 | 42 | 42 | 41 | 40 |
Shares Outstanding (Diluted) | 43 | 43 | 43 | 43 | 42 | 42 |
Shares Change | -1.08% | 0.09% | 0.45% | 1.27% | 1.04% | 1.26% |
EPS (Basic) | 1.89 | 1.49 | 1.25 | 1.14 | 1.29 | 1.30 |
EPS (Diluted) | 1.83 | 1.46 | 1.21 | 1.12 | 1.25 | 1.25 |
EPS Growth | 36.60% | 20.49% | 7.93% | -10.19% | 0% | 23.76% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 23.14 | 69.8 | 52.4 | 22.88 | 36.66 | 22.91 |
Free Cash Flow Per Share | 0.54 | 1.63 | 1.22 | 0.54 | 0.87 | 0.55 |
Dividend Per Share | - | - | 0.820 | 0.740 | 0.660 | 0.575 |
Dividend Growth | - | - | 10.81% | 12.12% | 14.78% | 18.56% |
Gross Margin | 41.88% | 41.16% | 37.58% | 35.79% | 36.38% | 36.02% |
Operating Margin | 14.83% | 13.84% | 12.81% | 15.41% | 17.70% | 17.72% |
Profit Margin | 8.92% | 7.60% | 7.07% | 7.08% | 9.65% | 11.55% |
Free Cash Flow Margin | 2.63% | 8.49% | 7.14% | 3.38% | 6.70% | 5.08% |
EBITDA | 146.11 | 128.58 | 107.82 | 119.66 | 110.2 | 90.76 |
EBITDA Margin | 16.59% | 15.64% | 14.69% | 17.70% | 20.13% | 20.12% |
D&A For EBITDA | 15.5 | 14.82 | 13.8 | 15.45 | 13.29 | 10.83 |
EBIT | 130.6 | 113.76 | 94.02 | 104.21 | 96.9 | 79.94 |
EBIT Margin | 14.83% | 13.84% | 12.81% | 15.41% | 17.70% | 17.72% |
Effective Tax Rate | 26.40% | 28.24% | 32.54% | 29.89% | 25.10% | 26.09% |